Therapeutic Efficacy of Wet Cupping on Uterine Inflammation in Primary Dysmenorrhea: An In Vivo Investigation Targeting Bilateral L4/L5 Vertebrae
DOI:
https://doi.org/10.48048/tis.2024.8304Keywords:
Primary dysmenorrhea, Wet cupping therapy, Dry cupping, PGF2α, Prostaglandin F receptor expressionAbstract
Primary dysmenorrhea (PD) is a prevalent problem in gynecology affecting the quality of life for young women. This medical condition is often responsible for the absence of young women from school or work, increasing the risk of developing hyperemesis gravidarum in the future. Furthermore, PD causes pain due to the activation of the local PGF2α pathway in the endometrium, which triggers oxidative stress processes, uterine ischemia and spasmodic uterine contractions. The first-line therapies for PD, Nonsteroid anti-inflammatory drugs (NSAIDs) and oral contraceptives, can cause side effects such as headache, nausea, intestinal ulcers and platelet abnormalities. To overcome the impact of PD, cupping has been proven effective as an alternative pain therapy with minimal side effects. Therefore, this study aimed to evaluate the effects of cupping on writing latency threshold time, PGF2α levels and FP receptor expression in PD model rats. The experiment was conducted using female Sprague Dawley rats to analyze the effects of wet cupping therapy (WCT) on inflammatory repair in the uterus. The method used was a pre- and post-test control group design, with 35 female rats randomly divided into 5 groups. These consisted of normal control (NC), negative control (C−), positive control (C+) + ibuprofen 7.2 mg, as well as treatment groups, comprising dry cupping (DC) and WCT. The results showed that writhing time threshold of WCT was the same as C+ (p = 0.368), while PGF2α decreased in DC (43.43 pg/mL, p = 0.008) and WCT (189.25 pg/mL, p = 0.0154). Similar to C+, WCT significantly decreased serum PGF2α levels compared to C−. WCT also influenced the expression of PTGFR subunit similarly to NC, showing the capacity to control the inflammatory pathway. The study suggested that WCT was a promising therapeutic strategy for PD by decreasing PGF2α and PTGFR expression.
HIGHLIGHTS
Previous investigations conducted on experimental animals using wet cupping therapy (WCT) have shown histopathological results associated with primary dysmenorrhea (PD) caused by estradiol benzoate and oxytocin. Moreover, this study shows the potential of WCT in reducing inflammation-induced PD pain by inhibiting the expression of PGF2α and PTGFR in the cyclooxygenase pathway, potentially increasing the pain threshold. The results show that WCT offers a potential alternative therapy for PD caused by estradiol benzoate and oxytocin.
GRAPHICAL ABSTRACT
Downloads
References
R Itani, L Soubra, S Karout, D Rahme, L Karout and HMJ Khojah. Primary dysmenorrhea: Pathophysiology, diagnosis, and treatment updates. Korean J. Fam. Med. 2022; 43, 101-8.
CA Enakpene, M Dalloul, C Petterkin-Caldwell, J Anopa and O Muneyyirci-Delale. Dysmenorrhea as a risk factor for Hyperemesis gravidarum. J. Clin. Gynecol. Obstet. 2015; 4, 283-9.
Y Cheng, Y Chu, X Su, K Zhang, Y Zhang, Z Wang, W Xiao, L Zhao and X Chen. Pharmacokinetic - pharmacodynamic modeling to study the anti-dysmenorrhea effect of Guizhi Fuling capsule on primary dysmenorrhea rats. Phytomedicine 2018; 48, 141-51.
Y Wei, T Ma, H Wang, J Xing, Y Wang, Z Gu, D Mu, Q Yin, X Cheng and C Wang. Extracts of compound Muniziqi granule suppressed uterus contraction and ameliorated oxytocin-induced primary dysmenorrhea. J. Ethnopharmacol. 2018; 223, 33-40.
TC de Lima Araújo, PMN Menezes, TF Ribeiro, CAF Macêdo, NAC de Souza, KSB Lima, HF de Figueredo, FS Silva and LA Rolim. Cannabis sativa L. roots from northeast Brazil reduce abdominal contortions in a mouse model of primary dysmenorrhea. J. Ethnopharmacol. 2024; 318, 116891.
M Tadese, A Kassa, AA Muluneh and G Altaye. Prevalence of dysmenorrhoea, associated risk factors and its relationship with academic performance among graduating female university students in Ethiopia: A cross-sectional study. BMJ Open 2021; 11, e043814.
RA Lobo, DM Gershenson, GM Lentz and FA Valea. Comprehensive gynecology e-book. 7th ed. Elsevier Health Sciences, Philadelphia, 2016.
DC Dutta, H Konar and DC Dutta. Textbook of gynecology: Including contraception. Jaypee Brothers Medical Publishers, New Delhi, India, 2013.
E Fernández-Martínez, MD Onieva-Zafra and ML Parra-Fernández. The impact of dysmenorrhea on quality of life among Spanish female university students. Int. J. Environ. Res. Publ. Health 2019; 16, 713.
SA Ryan. The treatment of dysmenorrhea. Pediatr. Clin. North Am. 2017; 64, 331-42.
CF Draper, K Duisters, B Weger, A Chakrabarti, AC Harms, L Brennan, T Hankemeier, L Goulet, T Konz, FP Martin, S Moco and JVD Greef. Menstrual cycle rhythmicity: Metabolic patterns in healthy women. Sci. Rep. 2018; 8, 14568.
Z Barcikowska, E Rajkowska-Labon, ME Grzybowska, R Hansdorfer-Korzon and K Zorena. Inflammatory markers in dysmenorrhea and therapeutic options. Int. J. Environ. Res. Publ. Health 2020; 17, 1191.
KA Kho and JK Shields. Diagnosis and management of primary dysmenorrhea. JAMA 2020; 323, 268-9.
N Muhammad, M Saeed and H Khan. Antipyretic, analgesic and anti-inflammatory activity of Viola betonicifolia whole plant. BMC Complementary Altern. Med. 2012; 12, 59.
MW Ha and SM Paek. Recent advances in the synthesis of ibuprofen and naproxen. Molecules 2021; 26, 4792.
E Ferries-Rowe, E Corey and JS Archer. Primary dysmenorrhea: Diagnosis and therapy. Obstet. Gynecol. 2020; 136, 1047-58.
Y Wei, T Ma, H Wang, J Xing, Y Wang, Z Gu, D Mu, Q Yin, X Cheng and C Wang. Extracts of compound Muniziqi granule suppressed uterus contraction and ameliorated oxytocin-induced primary dysmenorrhea. J. Ethnopharmacol. 2018; 223, 33-40.
J Gan, S Zhu, X Ma, X Ding, Y Deng, Y Wang and A Sun. The effect of Ding-kun-dan comparing with Marvelon on primary dysmenorrhea: A prospective, double-blind, multicenter, randomized controlled trial. J. Ethnopharmacol. 2024; 318, 116975.
H Cortes, H Hernández-Parra, SA Bernal-Chávez, IH Caballero-Florán, R Aguilar-Vázquez, MLD Prado-Audelo, M González-Torres, OD Reyes-Hernández, G Figueroa-González and G Leyva-Gómez. Current status of the therapeutic approach for dysmenorrhea. Cell. Mol. Biol. 2023; 69, 52-63.
M Taherpour, M Momeni, A Kazemi, F Ranjkesh, H Salimi and M Shakiba. The effects of dry cupping on primary dysmenorrhea: A randomized clinical trial. Nurs. Midwifery Stud. 2018; 7, 151-6.
NN Laila. Buku pintar menstruasi (in Indonesian). Buku Biru, Yogyakarta, Indonesia, 2011.
HB Hidayati, MH Machfoed, B Santoso and B Utomo. Bekam sebagai terapi alternatif untuk nyeri (in Indonesian). Neurona 2019; 36, 148-56.
AA Ridho. Bekam sinergi, cetakan 1 (in Indonesian). Aqwammedika, Jakarta, Indonesia, 2015.
H Nafees and A Anjum. Dry cupping therapy: A way forward in the management of primary dysmenorrhea. J. Pharm. Res. Int. 2021; 33, 46-52.
A Sultana, K Rahman, M Farzana and A Lone. Efficacy of hijamat bila shurt (dry cupping) on intensity of pain in dysmenorrhea - a preliminary study. Ancient Sci. Life 2010; 30, 47-50.
HA Rad, Z Basirat, F Bakouei, AA Moghadamnia, S Khafri, ZF Kotenaei, M Nikpour and S Kazemi. Effect of ginger and novafen on menstrual pain: A cross-over trial. Taiwan. J. Obstet. Gynecol. 2018; 57, 806-9.
R Mokaberinejad, Z Rampisheh, J Aliasl and E Akhtari. The comparison of fennel infusion plus dry cupping versus metformin in management of oligomenorrhoea in patients with polycystic ovary syndrome: A randomised clinical trial. J. Obstet. Gynaecol. 2019; 39, 652-8.
H Cao, X Li and J Liu. An updated review of the efficacy of cupping therapy. PloS One 2012; 7, e31793.
M Arslan, N Gökgöz and Ş Dane. The effect of traditional wet cupping on shoulder pain and neck pain: A pilot study. Complementary Ther. Clin. Pract. 2016; 23, 30-3.
EL Dalton and BJ Velasquez. Cupping therapy: An alternative method of treating pain. Publ. Health Open J. 2017; 2, 59-63.
H Kang. Sample size determination and power analysis using the G*power software. J. Educ. Eval. Health Prof. 2021; 18, 17.
J Charan and ND Kantharia. How to calculate sample size in animal studies? J. Pharmacol. Pharmacother. 2013; 4, 303-6.
X Wang, X Zhang, J Elliott, F Liao, J Tao and YK Jan. Effect of pressures and durations of cupping therapy on skin blood flow responses. Front. Bioeng. Biotechnol. 2020; 8, 1364.
R Ghods, N Sayfouri and MH Ayati. Anatomical features of the interscapular area where wet cupping therapy is done and its possible relation to acupuncture meridians. J. Acupunct. Meridian Stud. 2016; 9, 290-6.
W Bi, J Zhou, L Zhao, C Wang, W Wu, L Zhang, B Ji, N Zhang and F Zhou. Preventive effect of different citrus essential oils on primary dysmenorrhea: In vivo and in vitro study. Food Biosci. 2021; 42, 101135.
S Lestariningsih, D Tamtomo, S Sulistyowati, D Indarto and I Subadi. Three models of primary dysmenorrhea via estradiol benzoate and oxytocin induction: An experimental study. Rawal Med. J. 2024; 49, 176.
S Leary, T Grandin, C Greenacre, MA McCrackin, R Meyer, D Miller, J Shearer, T Turner and R Yanong. AVMA guidelines for the euthanasia of animals: 2020 edition. American Veterinary Medical Association, Schaumburg, Illinois, 2020.
N Zhang, F Kong, L Zhao, X Yang, W Wu, L Zhang, B Ji and F Zhou. Essential oil, juice, and ethanol extract from bergamot confer improving effects against primary dysmenorrhea in rats. J. Food Biochem. 2021; 45, e13614.
H Xiao, T Shi, L Han, R Tong and Z Liao. Mechanism of penehyclidine hydrochloride on a dysmenorrhea rat model. Drug Dev. Res. 2019; 80, 325-32.
A Kulkarni and S Deb. Dysmenorrhoea. Obstet. Gynaecol. Reprod. Med. 2019; 29, 286-91.
I Subadi, MK Kusumawardani, MF Qorib, I Susilo and HB Hidayati. Wet cupping therapy improves mu opioid receptor expression and pain threshold in animal models of inflammation. Anaesth. Pain Intensive Care 2019; 23, 348-52.
HB Hidayati, E Qurnianingsih, S Khaerunnisa, VA Puspamaniar and RD Susetyo. Wet cupping therapy increases the Time Withdrawal Latency (TWL) and decreases GABA-A receptor expression in the spinal cord in a rat model of neuropathic pain. Anaesth. Pain Intensive Care 2023; 27, 97-103.
S Furhad, RE Sina and AA Bokhari. Cupping therapy. StatPearls Publishing, Florida, United States, 2023.
M Li, J Bi, B Lv, W Zheng, Z Wang, W Xiao, Y Sun and E Li. An experimental study of the anti-dysmenorrhea effect of Chinese herbal medicines used in Jin Gui Yao Lue. J. Ethnopharmacol. 2019; 245, 112181.
L Yang, Z Cao, B Yu and C Chai. An in vivo mouse model of primary dysmenorrhea. Exp. Anim. 2015; 64, 295-303.
L Wu, Y Yang, M Lin, H Wang, L Li, H Wu, X Wang and M Yan. Unraveling the anti-primary dysmenorrhea mechanism of Ainsliaea fragrans Champ. extract by the integrative approach of network pharmacology and experimental verification. Phytomedicine 2024; 123, 155213.
AMN Al-Bedah, IS Elsubai, NA Qureshi, TS Aboushanab, GIM Ali, AT El-Olemy, AAH Khalil, MKM Khalil and MS Alqaed. The medical perspective of cupping therapy: Effects and mechanisms of action. J. Tradit. Complementary Med. 2018; 9, 90-7.
AR Benli and D Sunay. The effect of wet cupping therapy on a patient diagnosed with panic disorder. Asian J. Tradit. Complementary Altern. Med. 2018; 1, 27-31.
M Votrubec and I Thong. Neuropathic pain - a management update. Aust. Fam. Phys. 2013; 42, 92-7.
X Moisset and JP Lefaucheur. Non pharmacological treatment for neuropathic pain: Invasive and non-invasive cortical stimulation. Rev. Neurol. 2019; 175, 51-8.
S Mohamed, A Musa, N Agabna, S Shaddad and K Shaaban. Wet cupping induces endogenous opioid release in rats, a pilot study. J. Neurol. Sci. 2023; 455, 122207.
NM Al-Tawarah. Long-term after-effects of wet cupping therapy on some inflammatory mediators and antioxidant parameters in Jordanian healthy adult men. Bahrain Med. Bull. 2022; 44, 1025-30.
SM El Sayed, HS Mahmoud and MMH Nabo. Medical and scientific bases of wet cupping therapy (Al-hijamah): In light of modern medicine and prophetic medicine. Altern. Integr. Med. 2013; 2, 1000122.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Walailak University
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
